SALIX PHARMACEUTICALS LTD 4
4 · SALIX PHARMACEUTICALS LTD · Filed Jul 17, 2006
Insider Transaction Report
Form 4
Taylor David N MD
VP - Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2006-07-13+13,500→ 13,500 total
Holdings
- 10,500
Option to Buy Common Stock
[F2]Exercise: $17.63Exp: 2015-06-09→ Common Stock (10,500 underlying) - 100,000
Option to Buy Common Stock
[F3]Exercise: $22.76Exp: 2014-09-01→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock award which shall vest over 4 years at the rate of 25% on July 1, 2007, and then at the rate of 25% on each anniversary thereafter, subject to continued employment.
- [F2]Option vests at a rate of 1/48th per month, with a vesting commencement date of July 1, 2005.
- [F3]Option vests monthly over 48 months, with a 1/4 of the shares vesting on September 1, 2005 and the remainder vesting at a rate of 1/48th per month thereafter.
Signature
/s/ Donald R. Reynolds, by power of attorney|2006-07-17